載入...
Activating transcription factor 3 is crucial for antitumor activity and to strengthen the antiviral properties of Onconase
Onconase is a ribonuclease that presents both antitumor and antiviral properties linked to its ribonucleolytic activity and represents a new class of RNA-damaging drugs. It has reached clinical trials for the treatment of several cancers and human papilloma virus warts. Onconase targets different RN...
Na minha lista:
| 發表在: | Oncotarget |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Impact Journals LLC
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5355296/ https://ncbi.nlm.nih.gov/pubmed/28035074 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.14302 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|